Eli Lilly cuts revenue forecast, shares fall

U.S. drugmaker Eli Lilly and Co cut its full-year revenue forecast on Tuesday, as it predicted further hits from price declines in the United States and increased generic competition for drugs including erectile dysfunction treatment Cialis.